#3304 on the rich list of 14,644 insiders
Stuart A. Arbuckle
EVP, COO at Vertex Pharmaceuticals; Director at Rhythm Pharmaceuticals; Director at Praxis Precision Medicines. Based in Boston, Massachusetts.
$35.3M
in disclosed stock, −$1.0M (−2.79%) today
Market closed. Prices as of Nov 19, 4:04 PM ET
- Rank
- 3304th of 14,644
- Companies held
- 4
- Largest holding
- VRTX, 93.6% of total
- Latest SEC filing
- Jun 23, 2026
What the $35.3M is made of
Holdings counted
All filings on SEC.gov| Company | How held | Shares | Price | Value | Share of total | Reported |
|---|---|---|---|---|---|---|
| Vertex Pharmaceuticals VRTX Common Stock | Directly | 63,368 | $520.66 | $33.0M | 93.4% | Form 4, Jul 1, 2025 |
| Rhythm Pharmaceuticals RYTM Common Stock | Directly | 11,712 | $116.80 | $1.4M | 3.9% | Form 4, Jun 23, 2026 |
| Praxis Precision Medicines PRAX Common Stock | Directly | 2,537 | $310.90 | $789K | 2.2% | Form 4, Jun 10, 2026 |
| Alnylam Pharmaceuticals ALNY Common Stock | Directly | 671 | $147.82 | $99K | 0.3% | Form 4, May 20, 2026 |
| Vertex Pharmaceuticals VRTX Common Stock | Indirectly (see filing footnote) | 140 | $520.66 | $73K | 0.2% | Form 4, Jul 1, 2025 |
Share counts are the amounts Stuart A. Arbuckle reported owning after each line of their latest filing for that company, adjusted for any later stock splits. Values use the latest price. Methodology.
Nearby on the list
Full list| Rank | Name | Stock holdings |
|---|---|---|
| 3301 | Jack Hightower Chief Executive Officer, HighPeak Energy. Fort Worth, TX | $35.3M |
| 3302 | Lourenco Goncalves Chairman, President & CEO, Cleveland-Cliffs. Cleveland, OH | $35.3M |
| 3303 | Charles E. Bradley CEO, Consumer Portfolio Services. Las Vegas, NV | $35.3M |
| 3304 | Stuart A. Arbuckle EVP, COO, Vertex Pharmaceuticals. Boston, MA | $35.3M |
| 3305 | Jeetendra I. Patel President and CPO, Cisco Systems. San Jose, CA | $35.3M |
| 3306 | Jon Freier Chief Operating Officer, T-Mobile US. Bellevue, WA | $35.3M |
| 3307 | Terry J. Rosen Chief Executive Officer, Arcus Biosciences. Hayward, CA | $35.3M |
Other Vertex Pharmaceuticals insiders
All VRTX insiders- Reshma Kewalramani$45.0MCEO & President. #2739 overall
- Amit Sachdev$38.5MEVP Chief Patient & Ext Af Off. #3087 overall
- Ourania Tatsis$27.9MEVP, Chief Reg. & Quality Off.. #4003 overall
- Bruce I. Sachs$20.3MDirector. #5124 overall
- Jeffrey M. Leiden$18.3MExecutive Chairman. #4635 overall
- David Altshuler$18.0MEVP, Chief Scientific Officer. #5632 overall
Questions
How much stock does Stuart A. Arbuckle own?
Stuart A. Arbuckle holds $35,321,977 in listed stock based on SEC filings and current prices, mostly Vertex Pharmaceuticals (VRTX). That ranks 3304th on the Stock Rich List.
Is this Stuart A. Arbuckle's net worth?
No. It counts only listed shares reported on SEC Forms 3, 4 and 5. Cash, private companies, real estate, options and holdings that don't need to be reported are not included, so total net worth is likely different.